IsoPlexis

About:

IsoPlexis is a life science technology company that develops a single-cell detection system identifying patient immune responses.

Website: http://isoplexis.com

Top Investors: BlackRock, Perceptive Advisors, Northpond Ventures, National Institute on Aging, Connecticut Innovations

Description:

IsoPlexis is a life science technology company developing a single-cell detection system that identifies a wide range of patient immune responses at the single-cell level. Its platform can assess the safety and efficacy of therapeutics and monitor disease progression, enabling improved therapeutic development, and informing physician decisions. The company was founded in 2013 and is headquartered in Branford, Connecticut.